Transient rebounds of HIV plasma viremia are associated with the emergence of drug resistance mutations in patients on highly active antiretroviral therapy

This publication has 15 references indexed in Scilit:

• Viral Blip Dynamics during Highly Active Antiretroviral Therapy
  Journal of Virology, 2003
• The M184V mutation in HIV-1 reverse transcriptase reduces the restoration of wild-type replication by attenuated viruses
  AIDS, 2002
• Prevalence and clinical correlates of HIV viremia (`blips') in patients with previous suppression below the limits of quantification
  AIDS, 2002
• The clinical relevance of non-nucleoside reverse transcriptase inhibitor hypersusceptibility
  AIDS, 2002
• Intermittent and sustained low-level HIV viral rebound in patients receiving potent antiretroviral therapy
  AIDS, 2002
• The natural history and clinical significance of intermittent viraemia in patients with initial viral suppression to < 400 copies/ml
  AIDS, 2002
• HIV-1 Drug Resistance Profiles in Children and Adults With Viral Load of <50 Copies/mL Receiving Combination Therapy
  JAMA, 2001
• Human Immunodeficiency Virus Type 1–Infected Persons with Residual Disease and Virus Reservoirs on Suppressive Highly Active Antiretroviral Therapy Can Be Stratified into Relevant Virologic and Immunologic Subgroups
  The Journal of Infectious Diseases, 2001
• Predictors of Self-Reported Adherence and Plasma HIV Concentrations in Patients on Multidrug Antiretroviral Regimens
  JAIDS Journal of Acquired Immune Deficiency Syndromes, 2000
• Persistence of HIV-1 Transcription in Peripheral-Blood Mononuclear Cells in Patients Receiving Potent Antiretroviral Therapy
  New England Journal of Medicine, 1999